Cargando…
Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1(G93A) ALS mice: overlapping effects or limited therapeutic opportunity?
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is an adult onset neurodegenerative disease characterized by the loss of motoneurons (MNs) in the spinal cord, brainstem and motor cortex, causing progressive paralysis and death. Nowadays, there is no effective therapy and most patients die 2–5 years...
Autores principales: | Mancuso, Renzo, del Valle, Jaume, Morell, Marta, Pallás, Mercé, Osta, Rosario, Navarro, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035830/ https://www.ncbi.nlm.nih.gov/pubmed/24885036 http://dx.doi.org/10.1186/1750-1172-9-78 |
Ejemplares similares
-
Combined intramuscular and intraspinal transplant of bone marrow cells improves neuromuscular function in the SOD1(G93A) mice
por: Martínez-Muriana, Anna, et al.
Publicado: (2020) -
Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1(G93A) ALS Mice
por: Gaja-Capdevila, Núria, et al.
Publicado: (2021) -
Sigma-1 Receptor Stimulation with PRE-084 Ameliorates Myocardial Ischemia-Reperfusion Injury in Rats
por: Gao, Qi-Jun, et al.
Publicado: (2018) -
Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis
por: Lougheed, Rosamond, et al.
Publicado: (2011) -
Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography
por: Nagy, Janice A., et al.
Publicado: (2022)